是羅氏的試驗模型不一樣?還是真比·其他幾個好?PD-L1陽性響應率為26%,PD-L1陰性9.5%
回答: 我們Roche的免疫治療PD-L1藥物Atezolizumab在二線NSCLC顯現出對所有病人都工作, 不管PD-L1expre
由 riverflow2017
於 2017-08-31 20:11:21
WENXUECITY.COM does not represent or guarantee the truthfulness, accuracy, or reliability of any of communications posted by other users.
Copyright ©1998-2025 wenxuecity.com All rights reserved. Privacy Statement & Terms of Use & User Privacy Protection Policy